Exencial Wealth Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-9,176
Closed -$911K 273
2019
Q3
$911K Sell
9,176
-38
-0.4% -$3.61K 0.2% 111
2019
Q2
$852K Sell
9,214
-11,198
-55% -$1.06M 0.2% 107
2019
Q1
$1.93M Sell
20,412
-96,068
-82% -$8.4M 0.46% 71
2018
Q4
$7.46M Buy
+116,480
New +$8.6M 2% 5
2017
Q4
Sell
-1,491
Closed -$217K 189
2017
Q3
$217K Buy
+1,491
New +$203K 0.07% 163
2017
Q1
Sell
-4,116
Closed -$476K 178
2016
Q4
$476K Hold
4,116
0.2% 99
2016
Q3
$421K Buy
+4,116
New +$445K 0.19% 102

Other funds holding CELG

Exencial Wealth Advisors's CELG Position: Q4 2019 in Review

Exencial Wealth Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 9,176 shares — an estimated $911K sold.

Exencial Wealth Advisors first reported a position in CELG in Q3 2016 and held it in 7 quarters. The position peaked at $7.46M in Q4 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Exencial Wealth Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Exencial Wealth Advisors sold 9,176 Celgene Corp shares in Q4 2019, an estimated $911K.
  • Exencial Wealth Advisors first reported a position in Celgene Corp in Q3 2016 and held it in 7 quarters.
  • Exencial Wealth Advisors's Celgene Corp position peaked at $7.46M in Q4 2018.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Exencial Wealth Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.